These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 9424657
21. Percutaneous ethanol injection therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result. Lin SM, Lin DY, Lin CJ. Int J Clin Pract; 1999 Jun; 53(4):257-62. PubMed ID: 10563068 [Abstract] [Full Text] [Related]
23. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Orlando A, D'Antoni A, Cammà C, Albanese M, Livraghi T, Torzilli G, Virdone R, Sciarrino E, Simonetti RG, Maringhini A, Pagliaro L, Cottone M. Am J Gastroenterol; 2000 Oct; 95(10):2921-7. PubMed ID: 11051369 [Abstract] [Full Text] [Related]
24. [Short and long-term results of liver resection for hepatocarcinoma in Peru: a Peruvian single center experience on 232 cases]. Ruiz E, Sanchez J, Celis J, Payet E, Berrospi F, Chavez I, Young F. Rev Gastroenterol Peru; 2007 Oct; 27(3):223-37. PubMed ID: 17934536 [Abstract] [Full Text] [Related]
27. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. J Hepatol; 2008 Oct; 49(4):589-94. PubMed ID: 18620773 [Abstract] [Full Text] [Related]
34. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization]. Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH. Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805 [Abstract] [Full Text] [Related]
35. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates. Castroagudín JF, Delgado M, Villanueva A, Bustamante M, Martínez J, Otero E, Tomé S, Martínez SM, Segade FR, Conde R, Dominguez-Muñoz E, Varo E. Transplant Proc; 2005 Nov; 37(9):3871-3. PubMed ID: 16386568 [Abstract] [Full Text] [Related]
36. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection. Andriulli A, De Sio I, Brunello F, Salmi A, Solmi L, Facciorusso D, Caturelli E, Perri F. Aliment Pharmacol Ther; 2006 May 01; 23(9):1329-35. PubMed ID: 16629938 [Abstract] [Full Text] [Related]
37. [Treatment of primary hepatocarcinoma with chemoembolization and alcohol injection. Personal experience]. Florio F, Nardella M, Balzano S, Andriulli A, Caturelli E, Siena D, Bisceglia M, Fusilli S, Scarale MG, Cammisa M. Radiol Med; 1994 Dec 01; 88(6):821-6. PubMed ID: 7878242 [Abstract] [Full Text] [Related]
38. Survival factors after resection of small hepatocellular carcinoma. Wu FS, Zhao WH, Liang TB, Ma ZM, Teng LS, Wang M, Zheng SS. Hepatobiliary Pancreat Dis Int; 2005 Aug 01; 4(3):379-84. PubMed ID: 16109520 [Abstract] [Full Text] [Related]
39. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Tanikawa K, Majima Y. Hepatogastroenterology; 1993 Aug 01; 40(4):324-7. PubMed ID: 8406300 [Abstract] [Full Text] [Related]
40. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Cancer; 1996 May 01; 77(9):1792-6. PubMed ID: 8646676 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]